Pulmonx (LUNG) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Pulmonx (LUNG) over the last 6 years, with Q3 2025 value amounting to -$0.34.
- Pulmonx's EPS (Weighted Average and Diluted) rose 555.56% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.41, marking a year-over-year increase of 408.16%. This contributed to the annual value of -$1.44 for FY2024, which is 988.17% up from last year.
- Latest data reveals that Pulmonx reported EPS (Weighted Average and Diluted) of -$0.34 as of Q3 2025, which was up 555.56% from -$0.38 recorded in Q2 2025.
- In the past 5 years, Pulmonx's EPS (Weighted Average and Diluted) registered a high of -$0.28 during Q3 2021, and its lowest value of -$0.43 during Q1 2022.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.37, with a median of -$0.36 in 2021.
- The largest annual percentage gain for Pulmonx's EPS (Weighted Average and Diluted) in the last 5 years was 9414.63% (2021), contrasted with its biggest fall of 10502.09% (2021).
- Over the past 5 years, Pulmonx's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.36 in 2021, then dropped by 5.56% to -$0.38 in 2022, then increased by 5.26% to -$0.36 in 2023, then grew by 6.7% to -$0.34 in 2024, then fell by 1.22% to -$0.34 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.34 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.36 for Q1 2025.